- IBDEI0H1 ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,7672,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7672,1,3,0)
- ;;=3^DM Type 2 w/ CKD
- ;;^UTILITY(U,$J,358.3,7672,1,4,0)
- ;;=4^E11.22
- ;;^UTILITY(U,$J,358.3,7672,2)
- ;;=^5002630
- ;;^UTILITY(U,$J,358.3,7673,0)
- ;;=E11.319^^39^386^24
- ;;^UTILITY(U,$J,358.3,7673,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7673,1,3,0)
- ;;=3^DM Type 2 w/ Retinopathy Unspec w/o Macular Edema
- ;;^UTILITY(U,$J,358.3,7673,1,4,0)
- ;;=4^E11.319
- ;;^UTILITY(U,$J,358.3,7673,2)
- ;;=^5002633
- ;;^UTILITY(U,$J,358.3,7674,0)
- ;;=G40.909^^39^386^76
- ;;^UTILITY(U,$J,358.3,7674,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7674,1,3,0)
- ;;=3^Seizure Disorder NOS
- ;;^UTILITY(U,$J,358.3,7674,1,4,0)
- ;;=4^G40.909
- ;;^UTILITY(U,$J,358.3,7674,2)
- ;;=^5003865
- ;;^UTILITY(U,$J,358.3,7675,0)
- ;;=N52.9^^39^386^30
- ;;^UTILITY(U,$J,358.3,7675,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7675,1,3,0)
- ;;=3^Erectile Dysfuntion,Unspec
- ;;^UTILITY(U,$J,358.3,7675,1,4,0)
- ;;=4^N52.9
- ;;^UTILITY(U,$J,358.3,7675,2)
- ;;=^5015763
- ;;^UTILITY(U,$J,358.3,7676,0)
- ;;=I50.22^^39^386^39
- ;;^UTILITY(U,$J,358.3,7676,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7676,1,3,0)
- ;;=3^Heart Failure,Systolic,Chronic
- ;;^UTILITY(U,$J,358.3,7676,1,4,0)
- ;;=4^I50.22
- ;;^UTILITY(U,$J,358.3,7676,2)
- ;;=^5007241
- ;;^UTILITY(U,$J,358.3,7677,0)
- ;;=I50.32^^39^386^37
- ;;^UTILITY(U,$J,358.3,7677,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7677,1,3,0)
- ;;=3^Heart Failure,Diastolic,Chronic
- ;;^UTILITY(U,$J,358.3,7677,1,4,0)
- ;;=4^I50.32
- ;;^UTILITY(U,$J,358.3,7677,2)
- ;;=^5007245
- ;;^UTILITY(U,$J,358.3,7678,0)
- ;;=I50.42^^39^386^38
- ;;^UTILITY(U,$J,358.3,7678,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7678,1,3,0)
- ;;=3^Heart Failure,Systolic & Diastolic,Chronic
- ;;^UTILITY(U,$J,358.3,7678,1,4,0)
- ;;=4^I50.42
- ;;^UTILITY(U,$J,358.3,7678,2)
- ;;=^5007249
- ;;^UTILITY(U,$J,358.3,7679,0)
- ;;=I13.0^^39^386^32
- ;;^UTILITY(U,$J,358.3,7679,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7679,1,3,0)
- ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 1-4 Chr Kdny
- ;;^UTILITY(U,$J,358.3,7679,1,4,0)
- ;;=4^I13.0
- ;;^UTILITY(U,$J,358.3,7679,2)
- ;;=^5007067
- ;;^UTILITY(U,$J,358.3,7680,0)
- ;;=I13.2^^39^386^33
- ;;^UTILITY(U,$J,358.3,7680,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7680,1,3,0)
- ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 5 Chr Kdny
- ;;^UTILITY(U,$J,358.3,7680,1,4,0)
- ;;=4^I13.2
- ;;^UTILITY(U,$J,358.3,7680,2)
- ;;=^5007070
- ;;^UTILITY(U,$J,358.3,7681,0)
- ;;=I13.10^^39^386^34
- ;;^UTILITY(U,$J,358.3,7681,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7681,1,3,0)
- ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 1-4 Chr Kdny
- ;;^UTILITY(U,$J,358.3,7681,1,4,0)
- ;;=4^I13.10
- ;;^UTILITY(U,$J,358.3,7681,2)
- ;;=^5007068
- ;;^UTILITY(U,$J,358.3,7682,0)
- ;;=I13.11^^39^386^35
- ;;^UTILITY(U,$J,358.3,7682,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7682,1,3,0)
- ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 5 Chr Kdny
- ;;^UTILITY(U,$J,358.3,7682,1,4,0)
- ;;=4^I13.11
- ;;^UTILITY(U,$J,358.3,7682,2)
- ;;=^5007069
- ;;^UTILITY(U,$J,358.3,7683,0)
- ;;=E03.9^^39^386^45
- ;;^UTILITY(U,$J,358.3,7683,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7683,1,3,0)
- ;;=3^Hypothyroidism,Unspec
- ;;^UTILITY(U,$J,358.3,7683,1,4,0)
- ;;=4^E03.9
- ;;^UTILITY(U,$J,358.3,7683,2)
- ;;=^5002476
- ;;^UTILITY(U,$J,358.3,7684,0)
- ;;=C61.^^39^386^49
- ;;^UTILITY(U,$J,358.3,7684,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,7684,1,3,0)
- ;;=3^Malig Neopl Prostate
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0H1 3764 printed Feb 18, 2025@23:14:54 Page 2
- IBDEI0H1 ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,7672,1,0)
- +2 ;;=^358.31IA^4^2
- +3 ;;^UTILITY(U,$J,358.3,7672,1,3,0)
- +4 ;;=3^DM Type 2 w/ CKD
- +5 ;;^UTILITY(U,$J,358.3,7672,1,4,0)
- +6 ;;=4^E11.22
- +7 ;;^UTILITY(U,$J,358.3,7672,2)
- +8 ;;=^5002630
- +9 ;;^UTILITY(U,$J,358.3,7673,0)
- +10 ;;=E11.319^^39^386^24
- +11 ;;^UTILITY(U,$J,358.3,7673,1,0)
- +12 ;;=^358.31IA^4^2
- +13 ;;^UTILITY(U,$J,358.3,7673,1,3,0)
- +14 ;;=3^DM Type 2 w/ Retinopathy Unspec w/o Macular Edema
- +15 ;;^UTILITY(U,$J,358.3,7673,1,4,0)
- +16 ;;=4^E11.319
- +17 ;;^UTILITY(U,$J,358.3,7673,2)
- +18 ;;=^5002633
- +19 ;;^UTILITY(U,$J,358.3,7674,0)
- +20 ;;=G40.909^^39^386^76
- +21 ;;^UTILITY(U,$J,358.3,7674,1,0)
- +22 ;;=^358.31IA^4^2
- +23 ;;^UTILITY(U,$J,358.3,7674,1,3,0)
- +24 ;;=3^Seizure Disorder NOS
- +25 ;;^UTILITY(U,$J,358.3,7674,1,4,0)
- +26 ;;=4^G40.909
- +27 ;;^UTILITY(U,$J,358.3,7674,2)
- +28 ;;=^5003865
- +29 ;;^UTILITY(U,$J,358.3,7675,0)
- +30 ;;=N52.9^^39^386^30
- +31 ;;^UTILITY(U,$J,358.3,7675,1,0)
- +32 ;;=^358.31IA^4^2
- +33 ;;^UTILITY(U,$J,358.3,7675,1,3,0)
- +34 ;;=3^Erectile Dysfuntion,Unspec
- +35 ;;^UTILITY(U,$J,358.3,7675,1,4,0)
- +36 ;;=4^N52.9
- +37 ;;^UTILITY(U,$J,358.3,7675,2)
- +38 ;;=^5015763
- +39 ;;^UTILITY(U,$J,358.3,7676,0)
- +40 ;;=I50.22^^39^386^39
- +41 ;;^UTILITY(U,$J,358.3,7676,1,0)
- +42 ;;=^358.31IA^4^2
- +43 ;;^UTILITY(U,$J,358.3,7676,1,3,0)
- +44 ;;=3^Heart Failure,Systolic,Chronic
- +45 ;;^UTILITY(U,$J,358.3,7676,1,4,0)
- +46 ;;=4^I50.22
- +47 ;;^UTILITY(U,$J,358.3,7676,2)
- +48 ;;=^5007241
- +49 ;;^UTILITY(U,$J,358.3,7677,0)
- +50 ;;=I50.32^^39^386^37
- +51 ;;^UTILITY(U,$J,358.3,7677,1,0)
- +52 ;;=^358.31IA^4^2
- +53 ;;^UTILITY(U,$J,358.3,7677,1,3,0)
- +54 ;;=3^Heart Failure,Diastolic,Chronic
- +55 ;;^UTILITY(U,$J,358.3,7677,1,4,0)
- +56 ;;=4^I50.32
- +57 ;;^UTILITY(U,$J,358.3,7677,2)
- +58 ;;=^5007245
- +59 ;;^UTILITY(U,$J,358.3,7678,0)
- +60 ;;=I50.42^^39^386^38
- +61 ;;^UTILITY(U,$J,358.3,7678,1,0)
- +62 ;;=^358.31IA^4^2
- +63 ;;^UTILITY(U,$J,358.3,7678,1,3,0)
- +64 ;;=3^Heart Failure,Systolic & Diastolic,Chronic
- +65 ;;^UTILITY(U,$J,358.3,7678,1,4,0)
- +66 ;;=4^I50.42
- +67 ;;^UTILITY(U,$J,358.3,7678,2)
- +68 ;;=^5007249
- +69 ;;^UTILITY(U,$J,358.3,7679,0)
- +70 ;;=I13.0^^39^386^32
- +71 ;;^UTILITY(U,$J,358.3,7679,1,0)
- +72 ;;=^358.31IA^4^2
- +73 ;;^UTILITY(U,$J,358.3,7679,1,3,0)
- +74 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 1-4 Chr Kdny
- +75 ;;^UTILITY(U,$J,358.3,7679,1,4,0)
- +76 ;;=4^I13.0
- +77 ;;^UTILITY(U,$J,358.3,7679,2)
- +78 ;;=^5007067
- +79 ;;^UTILITY(U,$J,358.3,7680,0)
- +80 ;;=I13.2^^39^386^33
- +81 ;;^UTILITY(U,$J,358.3,7680,1,0)
- +82 ;;=^358.31IA^4^2
- +83 ;;^UTILITY(U,$J,358.3,7680,1,3,0)
- +84 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 5 Chr Kdny
- +85 ;;^UTILITY(U,$J,358.3,7680,1,4,0)
- +86 ;;=4^I13.2
- +87 ;;^UTILITY(U,$J,358.3,7680,2)
- +88 ;;=^5007070
- +89 ;;^UTILITY(U,$J,358.3,7681,0)
- +90 ;;=I13.10^^39^386^34
- +91 ;;^UTILITY(U,$J,358.3,7681,1,0)
- +92 ;;=^358.31IA^4^2
- +93 ;;^UTILITY(U,$J,358.3,7681,1,3,0)
- +94 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 1-4 Chr Kdny
- +95 ;;^UTILITY(U,$J,358.3,7681,1,4,0)
- +96 ;;=4^I13.10
- +97 ;;^UTILITY(U,$J,358.3,7681,2)
- +98 ;;=^5007068
- +99 ;;^UTILITY(U,$J,358.3,7682,0)
- +100 ;;=I13.11^^39^386^35
- +101 ;;^UTILITY(U,$J,358.3,7682,1,0)
- +102 ;;=^358.31IA^4^2
- +103 ;;^UTILITY(U,$J,358.3,7682,1,3,0)
- +104 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 5 Chr Kdny
- +105 ;;^UTILITY(U,$J,358.3,7682,1,4,0)
- +106 ;;=4^I13.11
- +107 ;;^UTILITY(U,$J,358.3,7682,2)
- +108 ;;=^5007069
- +109 ;;^UTILITY(U,$J,358.3,7683,0)
- +110 ;;=E03.9^^39^386^45
- +111 ;;^UTILITY(U,$J,358.3,7683,1,0)
- +112 ;;=^358.31IA^4^2
- +113 ;;^UTILITY(U,$J,358.3,7683,1,3,0)
- +114 ;;=3^Hypothyroidism,Unspec
- +115 ;;^UTILITY(U,$J,358.3,7683,1,4,0)
- +116 ;;=4^E03.9
- +117 ;;^UTILITY(U,$J,358.3,7683,2)
- +118 ;;=^5002476
- +119 ;;^UTILITY(U,$J,358.3,7684,0)
- +120 ;;=C61.^^39^386^49
- +121 ;;^UTILITY(U,$J,358.3,7684,1,0)
- +122 ;;=^358.31IA^4^2
- +123 ;;^UTILITY(U,$J,358.3,7684,1,3,0)
- +124 ;;=3^Malig Neopl Prostate
